IL5 and myeloid sarcoma: In MS, IL-5 has been associated with immunomodulatory effects, promoting the production of anti-inflammatory cytokines and the expression of regulatory T cells (Tregs), crucial for maintaining immune tolerance and preventing autoimmunity.